In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a oxerutin Drug Master File in Korea (oxerutin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of oxerutin. The MFDS reviews the oxerutin KDMF as part of the drug registration process and uses the information provided in the oxerutin KDMF to evaluate the safety and efficacy of the drug.
After submitting a oxerutin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their oxerutin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of oxerutin suppliers with KDMF on PharmaCompass.